SEC Form 4 · accession 0001123292-18-000597
PRECIGEN, INC. · PGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cesar L Alvarez
Director
Period of report
Mar 23, 2018
Accepted (ET)
Mar 29, 2018 · 5:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356090
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Mar 23, 2018 | A | 7,911 | A | — | — | Common Stock | 7,911 | 7,911 | D |
| Option to Purchase Common Stock (Right to Buy) | $15.80 | Mar 23, 2018 | A | 14,246 | A | Mar 23, 2018 | Mar 23, 2028 | Common Stock | 14,246 | 14,246 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of XON common stock.
- F2The restricted stock units vest in full one year from the grant date.